Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience
Authors:
- Łukasz NykŁukasz Nyk
- Hubert KameckiHubert Kamecki
- Wojciech KrajewskiWojciech Krajewski
- Bartosz MałkiewiczBartosz Małkiewicz
- Tomasz SzydełkoTomasz Szydełko
- Markiian KubisMarkiian Kubis
- Marcin SłojewskiMarcin Słojewski
- Piotr KrystPiotr Kryst
- Sławomir PoletajewSławomir Poletajew
- Wojciech MalewskiWojciech Malewski
Open Access
- 11 April 2022
- journal article
- research article
- Published by MDPI AG in Tomography
- Vol. 8 (2) , 1090-1096
Abstract
We aimed to retrospectively analyze consecutive prostate cancer patients diagnosed with biochemical or clinical recurrence after local treatment with curative intent, with no evidence of distant metastases, who underwent positron emission tomography/computed tomography (PET/CT) with choline followed by salvage lymph node dissection (SLND) in three academic centers between 2013 and 2020. A total of 27 men were included in the analyses. Sensitivity, specificity, positive and negative predictive values, and accuracy of choline-PET/CT in predicting pathology-proven lymph node involvement were 75%, 43%, 79%, 38% and 67% on per-patient and 70%, 86%, 80%, 78%, and 79% on per-site analyses, respectively, with the differences in specificity and NPV between per-patient and per-site analyses being statistically significant (p = 0.03 and 0.04, respectively). The study provides further insight into the role of preoperative choline-PET/CT in patients undergoing SLND for recurrent PC.Keywords
This publication has 16 references indexed in Scilit:
- Use of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literatureBJU International, 2019
- Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic ReviewEuropean Urology, 2019
- Role of PET imaging for biochemical recurrence following primary treatment for prostate cancerTranslational Andrology and Urology, 2018
- The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysisWorld Journal of Urology, 2018
- Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatmentOncotarget, 2018
- Predictive factors of biochemical recurrence after radical prostatectomy for high‐risk prostate cancerInternational Journal of Urology, 2018
- Radiolabeled choline PET/CT before salvage lymphadenectomy dissectionNuclear Medicine Communications, 2016
- Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical ProstatectomyJournal of Urology, 2016
- Stem Cells, Biomarkers and Genetic Profiling: Approaching Future Challenges in UrologyUrologia Journal, 2016
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted TherapyJournal of Nuclear Medicine, 2015